Brain implants, made from small clusters of brain cells, could help restore neural pathways damaged by Parkinson’s disease.

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Lewy body diseases (LBDs) are a class of debilitating neurodegenerative disorders linked to the abnormal aggregation of the ...

Researchers have discovered how a cell surface protein called Aplp1 can play a role in spreading material responsible for ...

Nicole LaBolle initially dismissed her shaking as something fairly common before facing a Parkinson's diagnosis at 28 ...

Racial disparities in mortality are increasing. This article explores how the production of DNA-edited ethnically diverse ...

Ozzy Osbourne is struggling to walk amid his battle with Parkinson’s disease, but his singing voice is “as good as ever,” ...

The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...

Yes, Parkinson's is a disease that effects nerve cells in the brain, leading to tremors, stiffness, speech changes and more, according to Mayo Clinic. However, there is growing evidence that the ...

Advanced 'Parkinson's in a Dish' Model Accelerates Brain Disease Research July 29, 2024 — Researchers have developed a model that rapidly converts stem cells to brain cells with protein ...